AP
VRTX icon

Atwood & Palmer’s Vertex Pharmaceuticals VRTX Stock Holding History

Atwood & Palmer’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28M Buy
56,357
+604
+1% +$268K 1.49% 31
2026
Q1 		$24.9M Buy
55,753
+361
+0.7% +$168K 1.4% 33
2025
Q4 		$25.1M Buy
55,392
+95
+0.2% +$40.9K 1.43% 30
2025
Q3 		$21.7M Buy
55,297
+105
+0.2% +$43.9K 1.27% 35
2025
Q2 		$24.6M Buy
55,192
+208
+0.4% +$95.9K 1.54% 27
2025
Q1 		$26.7M Sell
54,984
-406
-0.7% -$189K 1.85% 21
2024
Q4 		$22.3M Buy
55,390
+1,130
+2% +$524K 1.53% 31
2024
Q3 		$25.2M Sell
54,260
-15
-0% -$7.21K 1.72% 25
2024
Q2 		$25.4M Buy
54,275
+142
+0.3% +$61.6K 1.93% 21
2024
Q1 		$22.6M Buy
54,133
+1,633
+3% +$690K 1.72% 24
2023
Q4 		$21.4M Buy
52,500
+180
+0.3% +$66.5K 1.73% 25
2023
Q3 		$18.2M Buy
52,320
+145
+0.3% +$50.7K 1.59% 27
2023
Q2 		$18.4M Buy
+52,175
New +$17.6M 1.64% 23
2017
Q4 		– Sell
-100
Closed -$15K – 302
2017
Q3 		$15K Buy
+100
New +$15.1K ﹤0.01% 242

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
BIAS
Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Atwood & Palmer's VRTX Position: Q2 2026 in Review

Atwood & Palmer increased its Vertex Pharmaceuticals (VRTX) stake by 1.1% in Q2 2026, buying an estimated $268K and bringing the position to 56,357 shares worth $28M. The position accounts for 1.49% of the portfolio, ranked #31.

Atwood & Palmer first reported a position in VRTX in Q3 2017 and has held it in 14 quarters since. 256 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Atwood & Palmer held 56,357 shares of Vertex Pharmaceuticals worth $28M as of Q2 2026.
  • Atwood & Palmer bought 604 Vertex Pharmaceuticals shares in Q2 2026, an estimated $268K.
  • Vertex Pharmaceuticals made up 1.49% of Atwood & Palmer's portfolio in Q2 2026, its #31 holding.
  • Atwood & Palmer first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 14 quarters since.
  • 256 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.